Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis

Metabolic Brain Disease

Volumn 21, Issue 2-3, 2006, Pages 121-137

  Van Rensburg, S J ^a   Kotze, M J ^b   Hon, D ^a   Haug, P ^c   Kuyler, J ^d   Hendricks, M ^c   Botha, J ^c   Potocnik, F C V ^c   Matsha, T ^a   Erasmus, R T ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b Christiaan Barnard Memorial Hospital   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d Panorama Medi Clinic   (South Africa)

Author keywords

EDSS; Homocysteine; Iron; Multiple sclerosis; Myelin regeneration; Nutrition

Indexed keywords

ANTIINFLAMMATORY AGENT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; INTERFERON; IRON; PREDNISONE;

ADULT; ARTICLE; BLOOD; CAUCASIAN; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HUMAN; MALE; METABOLISM; METHYLATION; MULTIPLE SCLEROSIS; NEGRO; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL STATUS; PATIENT COMPLIANCE; PILOT STUDY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTI-INFLAMMATORY AGENTS; DIETARY FATS; DIETARY SUPPLEMENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INTERFERONS; IRON; MAGNETIC RESONANCE IMAGING; MALE; METHYLATION; MULTIPLE SCLEROSIS; NUTRITIONAL STATUS; PATIENT COMPLIANCE; PILOT PROJECTS; PREDNISONE; VITAMIN B 12;

EID: 39049177338     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-006-9019-0     Document Type: Article

References (42)

1. Badenoch J, Evans JR,RichardsWCD(1959) The stomach in hypochromic anaemia. Brit J Haemat 3:175-185
2. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-68 (Pubitemid 38391962)
3. Beard JL, Wiesinger JA, Connor JR (2003) Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev Neurosci 25:308-315 (Pubitemid 37465056)
4. Clausen J (1993) Mercury and multiple sclerosis. Acta Neurol Scand 87:461-464
5. Connor JR, Menzies SL (1996) Relationship of iron to oligodendrocytes and myelination. Glia 17:83-93
6. Cox EV,Meynell MJ,GaddieR,CookeWT (1959) Inter-relation of vitamin B12 and iron. Lancet: ii 998-1001
7. Davidson WMB, Markson JL (1955) The gastric mucosa in iron-deficiency anemia. Lancet ii 639
8. Dean G, Bhigjee AI, Bill PL, Fritz V, Chikanza IC, Thomas JE, Levy LF, Saffer D (1994) Multiple sclerosis in black South Africans and Zimbabweans. J Neurol Neurosurg Psychiatry 57:1064-1069
9. De Villiers, JNP, Treurnicht FK, Warnich L, Carr J, Kotze MJ (2006) Analysis of viral and genetic factors in South African patients with multiple sclerosis. Metabolic Brain Disease (In press) 21:
10. Field EJ, Joyce G (1983) Multiple sclerosis: effect of gamma linolenate administration upon membranes and the need for extended clinical trials of unsaturated fatty acids. Eur Neurol 22:78-83 (Pubitemid 13189821)
11. Fitzsimons EJ, Brock JH (2001) Editorial: The anaemia of chronic disease. BMJ 322:811-812
12. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Ohman S, Racke MK, Sharief M, Sindic CJ, Sellebjerg F, Tourtellotte WW (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62:865-870 (Pubitemid 40973448)
13. Frequin ST, Wevers RA, Braam M, Barkhof F, Hommes OR (1993) Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone. J Neurol 240:305-308 (Pubitemid 23202743)
14. Grant SM, Wiesinger JA, Beard JL, Cantorna MT (2003) Iron-deficient mice fail to develop autoimmune encephalomyelitis. J Nutr 133:2635-2638 (Pubitemid 36935983)
15. Helming L, Bose J, Ehrchen J, Schiebe S, Frahm T, Geffers R, Probst-Kepper M, Balling R, Lengeling A (2005) 1α, 25-dihydroxyvitamin D3 is a potent suppressor of interferon-γ mediated macrophage activation. Blood. 2005 Aug 23; [Epub ahead of print]
16. Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor JR (1999) Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 72:868-874 (Pubitemid 29055254)
17. Jensen GE, Clausen J (1984) Glutathione peroxidase and reductase, glucose-6-phosphate dehydrogenase and catalase activities in multiple sclerosis. J Neurol Sci 63:45-53 (Pubitemid 14178552)
18. Kolesar T (2000) What is the cause of low concentration of B12 in cerebrovascular fluid in multiple sclerosis? Lakartidningen 97:3644-3645
19. Kotze MJ, de Villiers JN, Rooney RN, Grobbelaar JJ, Mansvelt EP, Bouwens CS, Carr J, Stander I, du Plessis L (2001) Analysis of the NRAMP1 gene implicated in iron transport: association with multiple sclerosis and age effects. Blood Cells Mol Dis 27:44-53 (Pubitemid 32299753)
20. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
21. Kwik-Uribe CL, Gietzen D, German JB, Golub MS, Keen CL (2000). Chronic marginal iron intakes during early development in mice result in persistent changes in dopamine metabolism and myelin composition. J Nutr 130:2821-2830
22. LeVine SM, Chakrabarty A (2004) The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 1012:252-266 (Pubitemid 38453530)
23. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
24. Nordvik I, Myhr KM, Nyland H, Bjerve KS (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102:143-149 (Pubitemid 30645133)
25. Oloyede OB, Folayan AT, Odutuga AA (1992) Effects of low-iron status and deficiency of essential fatty acids on some biochemical constituents of rat brain. Biochem Int 27:913-922
26. Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J, Connor JR (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77:681-689 (Pubitemid 39194609)
27. Poser CM, Brinar VV (2004) Diagnostic criteria for multiple sclerosis: an historical review. Clin Neurol Neurosurg 106:147-58 (Pubitemid 38716141)
28. Reynolds EH (1992) Multiple sclerosis and vitamin B12 metabolism. J Neuroimmunol 40:225-30
29. Rooney RN, Kotze MJ, de Villiers JN, Hillermann R, Cohen JA (1999) Multiple sclerosis, porphyria-like symptoms, and a history of iron deficiency anemia in a family of Scottish descent. Am J Med Genet 86:194-196
30. Saleh MC, Espinosa de los Monteros A, de Arriba Zerpa GA, Fontaine I, Piaud O, Djordjijevic D, Baroukh N, Garcia Otin AL, Ortiz E, Lewis S, Fiette L, Santambrogio P, Belzung C, Connor JR, de Vellis J, Pasquini JM, Zakin MM, Baron B, Guillou F (2003) Myelination and motor coordination are increased in transferrin transgenic mice. J Neurosci Res 72:587-594
31. Selzer RR, Rosenblatt DS, Laxova R, Hogan K (2003) Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med 349:45-50 (Pubitemid 36765102)
32. Shukla VK, Jensen GE, Clausen J (1977) Erythrocyte glutathione perioxidase deficiency in multiple sclerosis. Acta Neurol Scand 56:542-550 (Pubitemid 8282886)
33. Steinman L (1993) Autoimmune disease. Scientific American 269:75-83
34. Surtees R, Leonard J, Austin S (1991) Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338:1550-1554
35. Syburra C, Passi S (1999) Oxidative stress in patients with multiple sclerosis. Ukr Biokhim Zh 71:112-115
36. Szeinberg A, Golan R, Ben Ezzer J, Sarova Pinhas I, Sadeh M, Braham J (1979) Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta Neurol Scand 60:265-271 (Pubitemid 10182757)
37. Toshniwal PK, Zarling EJ (1992) Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem Res 17:205-207
38. Valberg LS, Flanagan PR, Kertesz A, Ebers GC (1989) Abnormalities in iron metabolism inmultiple sclerosis. Can J Neurol Sci 16:184-186 (Pubitemid 19161244)
39. Van Rensburg SJ, van Zyl JM, Hon D, Daniels WMU, Hendricks J, Potocnik FCV, Erasmus R (2004) Biochemical model for inflammation of the brain: the effect of iron and transferrin on monocytes and lipid peroxidation. Metabolic Brain Disease 19:97-112 (Pubitemid 39005629)
40. Vrethem M, Mattsson E, Hebelka H, Leerbeck K, Osterberg A, Landtblom AM, Balla B, Nilsson H, Hultgren M, Brattstrom L, Kagedal B (2003) Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler 9:239-245 (Pubitemid 36681888)
41. Wikstrom J,Westermarck T, Palo J (1976) Selenium, vitamin E and copper in multiple sclerosis. Acta-Neurol- Scand 54:287-290
42. Yu GS, Steinkirchner TM, Rao GA, Larkin EC (1986) Effect of prenatal iron deficiency on myelination in rat pups. Am J Pathol 125:620-624 (Pubitemid 17208848)